BSE filing, NSE: UFLEX. Summary written from the filing by ALFA Finder's alert engine.
Uflex Ltd: key numbers
- Share price
- ₹582.00
- Market cap
- ₹4,203 Cr
- Revenue (annual)
- ₹15,401 Cr
- Net profit (annual)
- ₹317.1 Cr
- P/E (TTM)
- 6.2×Sector 36.4×
- Promoter holding
- 44.58%+0.00% QoQ
- FII holding
- 9.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Uflex Ltd
All →Uflex Credit Rating
CRISIL Ratings has reaffirmed the credit ratings for Uflex Limited's total bank loan facilities of Rs. 4,600 Crore. The ratings remain unchanged for the company.
- Value
- ₹4,600 Cr
Uflex Credit Rating
Ind-Ra affirmed Uflex's bank loan facilities at IND AA-/Stable/IND A1+. The stable outlook unchanged signals continued creditworthiness of the company's debt structure.
Uflex Annual General Meeting
UFLEX Limited has issued a postal ballot notice seeking shareholder approval to increase the company's borrowing powers to a limit of Rs. 5,000 Crore.
Uflex Investor Presentation: Key Takeaways
UFlex reported strong Q1 FY27 results with 37.6% YoY revenue growth. Strategy focuses on aseptic packaging, sustainability via 'Project Plastic Fix', and global capacity expansion to drive margins.
- Call
- Guides 35% growth
Uflex Patent
UFlex Limited received a patent from the Government of India for its 'High-Speed Twin Aseptic Pack Packaging Machine for Liquid Products'.
Uflex Other Announcement
Uflex Limited disclosed an unsolicited ESG rating of 58/100 assigned by Crisil ESG Ratings & Analytics Limited.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.